9 master students are joining MINT
Sifon Edem who received a BSc in Pharmacy at the University of Uyo, Nigeria will work for the next 6 months under the supervision of Dr. Franck Letournel and Dr. Emilie Roger on Vectorisation of Cyclosporin A for intranasal treatment of Glioblastoma Stem Cells (GSCs), for the 2nd year of the Erasmus Mundus Master's degree in Nanomedicines for Drug delivery.
Nour Hashem who received a BSc in Pharmacy at Lebanese International University will work for the next 6 months under the Supervision of Professor M. Bonnin , Professor G. Lefebvre , Professor J-C Gimel and Professor B. Calvignac on Microfluidic formulation on PLGA-based nanoparticles for the encapsulation of Amiodarone , for completing thesis in Master 2 in nanomedicine and pharmaceutical R&D at University of Angers.
Nur E Hasnat who received a MS in Pharmaceutical Technology at University of Asia Pacific, Bangladesh will work for the next 6 months under the supervision of Dr. Laurent Lemaire, on Osmotic disrupting nanosystem, for completing thesis of Erasmus Mundus Joint Master's Degree of Nanomedicine for Drug Delivery.
Eva Martin, who received a BSc in cell biology and animal physiology from the University of Lorraine, Faculty of Sciences and Technologies of Nancy will work for the next 6 months under the direction of Professor N. Clere and C. Bourreau, on the effect of endothelial-mesenchymal transition on the response to treatments of non-small cell bronchial carcinomas, for the 2nd year of her Master's degree.
Catherine Nadeau is a final-year student in the Bachelor of Biopharmaceutical Sciences program at the Université de Montréal, Canada. For the next four months, she will be working under the supervision of Professor E. Roger on the encapsulation of nisin in a novel oral delivery system.
Abhinandan Nandrajog who received a Bachelor of Pharmacy at Panjab University, Chandigarh will work for the next 6 months under the supervision of Professor G. Bastiat and Dr Joohee Prak, on lipid nanoparticles-based hydrogel as a solution to prevent intimal hyperplasia, as the thesis for the final semester of 2nd year of NANOMED EMJMD."
